174 related articles for article (PubMed ID: 26369825)
1. Targeting the Atypical Chemokine Receptor ACKR3/CXCR7: Phase 1 - Phage Display Peptide Identification and Characterization.
Vestal RD; LaJeunesse DR; Taylor EW
Curr Top Med Chem; 2016; 16(13):1427-40. PubMed ID: 26369825
[TBL] [Abstract][Full Text] [Related]
2. Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12.
Benredjem B; Girard M; Rhainds D; St-Onge G; Heveker N
J Biol Chem; 2017 Jan; 292(1):31-42. PubMed ID: 27875312
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonists.
Szpakowska M; Meyrath M; Reynders N; Counson M; Hanson J; Steyaert J; Chevigné A
Biochem Pharmacol; 2018 Jul; 153():299-309. PubMed ID: 29530506
[TBL] [Abstract][Full Text] [Related]
4. Common structural interactions between the receptors CXCR3, CXCR4 and CXCR7 complexed with their natural ligands, CXCL11 and CXCL12, by a modeling approach.
Costantini S; Raucci R; De Vero T; Castello G; Colonna G
Cytokine; 2013 Oct; 64(1):316-21. PubMed ID: 23773308
[TBL] [Abstract][Full Text] [Related]
5. Dual targeting of the chemokine receptors CXCR4 and ACKR3 with novel engineered chemokines.
Hanes MS; Salanga CL; Chowdry AB; Comerford I; McColl SR; Kufareva I; Handel TM
J Biol Chem; 2015 Sep; 290(37):22385-97. PubMed ID: 26216880
[TBL] [Abstract][Full Text] [Related]
6. Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3.
Szpakowska M; Nevins AM; Meyrath M; Rhainds D; D'huys T; Guité-Vinet F; Dupuis N; Gauthier PA; Counson M; Kleist A; St-Onge G; Hanson J; Schols D; Volkman BF; Heveker N; Chevigné A
Br J Pharmacol; 2018 May; 175(9):1419-1438. PubMed ID: 29272550
[TBL] [Abstract][Full Text] [Related]
7. The relevance of the chemokine receptor ACKR3/CXCR7 on CXCL12-mediated effects in cancers with a focus on virus-related cancers.
Freitas C; Desnoyer A; Meuris F; Bachelerie F; Balabanian K; Machelon V
Cytokine Growth Factor Rev; 2014 Jun; 25(3):307-16. PubMed ID: 24853339
[TBL] [Abstract][Full Text] [Related]
8. Structure-Activity Relationship Study of Cyclic Pentapeptide Ligands for Atypical Chemokine Receptor 3 (ACKR3).
Sekiguchi H; Kuroyanagi T; Rhainds D; Kobayashi K; Kobayashi Y; Ohno H; Heveker N; Akaji K; Fujii N; Oishi S
J Med Chem; 2018 Apr; 61(8):3745-3751. PubMed ID: 29608300
[TBL] [Abstract][Full Text] [Related]
9. Ligand-specific conformational transitions and intracellular transport are required for atypical chemokine receptor 3-mediated chemokine scavenging.
Montpas N; St-Onge G; Nama N; Rhainds D; Benredjem B; Girard M; Hickson G; Pons V; Heveker N
J Biol Chem; 2018 Jan; 293(3):893-905. PubMed ID: 29180449
[TBL] [Abstract][Full Text] [Related]
10. Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7.
Szpakowska M; Dupuis N; Baragli A; Counson M; Hanson J; Piette J; Chevigné A
Biochem Pharmacol; 2016 Aug; 114():14-21. PubMed ID: 27238288
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a chimeric chemokine as a specific ligand for ACKR3.
Ameti R; Melgrati S; Radice E; Cameroni E; Hub E; Thelen S; Rot A; Thelen M
J Leukoc Biol; 2018 Aug; 104(2):391-400. PubMed ID: 29601107
[TBL] [Abstract][Full Text] [Related]
12. Development of novel CXC chemokine receptor 7 (CXCR7) ligands: selectivity switch from CXCR4 antagonists with a cyclic pentapeptide scaffold.
Oishi S; Kuroyanagi T; Kubo T; Montpas N; Yoshikawa Y; Misu R; Kobayashi Y; Ohno H; Heveker N; Furuya T; Fujii N
J Med Chem; 2015 Jul; 58(13):5218-25. PubMed ID: 26042340
[TBL] [Abstract][Full Text] [Related]
13. Decreased ACKR3 (CXCR7) function causes oculomotor synkinesis in mice and humans.
Whitman MC; Miyake N; Nguyen EH; Bell JL; Matos Ruiz PM; Chan WM; Di Gioia SA; Mukherjee N; Barry BJ; Bosley TM; Khan AO; Engle EC
Hum Mol Genet; 2019 Sep; 28(18):3113-3125. PubMed ID: 31211835
[TBL] [Abstract][Full Text] [Related]
14. Novel insights into neuroinflammation: bacterial lipopolysaccharide, tumor necrosis factor α, and Ureaplasma species differentially modulate atypical chemokine receptor 3 responses in human brain microvascular endothelial cells.
Silwedel C; Speer CP; Haarmann A; Fehrholz M; Claus H; Buttmann M; Glaser K
J Neuroinflammation; 2018 May; 15(1):156. PubMed ID: 29792190
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of ligand interaction with atypical chemokine receptor 3.
Gustavsson M; Wang L; van Gils N; Stephens BS; Zhang P; Schall TJ; Yang S; Abagyan R; Chance MR; Kufareva I; Handel TM
Nat Commun; 2017 Jan; 8():14135. PubMed ID: 28098154
[TBL] [Abstract][Full Text] [Related]
16. CXCR7 impact on CXCL12 biology and disease.
Sánchez-Martín L; Sánchez-Mateos P; Cabañas C
Trends Mol Med; 2013 Jan; 19(1):12-22. PubMed ID: 23153575
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological Characterization and Radiolabeling of VUF15485, a High-Affinity Small-Molecule Agonist for the Atypical Chemokine Receptor ACKR3.
Zarca AM; Adlere I; Viciano CP; Arimont-Segura M; Meyrath M; Simon IA; Bebelman JP; Laan D; Custers HGJ; Janssen E; Versteegh KL; Buzink MCML; Nesheva DN; Bosma R; de Esch IJP; Vischer HF; Wijtmans M; Szpakowska M; Chevigné A; Hoffmann C; de Graaf C; Zarzycka BA; Windhorst AD; Smit MJ; Leurs R
Mol Pharmacol; 2024 Mar; 105(4):301-312. PubMed ID: 38346795
[TBL] [Abstract][Full Text] [Related]
18. CXCR7 prevents excessive CXCL12-mediated downregulation of CXCR4 in migrating cortical interneurons.
Abe P; Mueller W; Schütz D; MacKay F; Thelen M; Zhang P; Stumm R
Development; 2014 May; 141(9):1857-63. PubMed ID: 24718993
[TBL] [Abstract][Full Text] [Related]
19. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
Nazari A; Khorramdelazad H; Hassanshahi G
Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
[TBL] [Abstract][Full Text] [Related]
20. Atypical Chemokine Receptor 3 (ACKR3): A Comprehensive Overview of its Expression and Potential Roles in the Immune System.
Koenen J; Bachelerie F; Balabanian K; Schlecht-Louf G; Gallego C
Mol Pharmacol; 2019 Dec; 96(6):809-818. PubMed ID: 31040166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
